{"id":"W2922002660","doi":"10.1200/jco.2019.37.7_suppl.98","title":"Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Prednisone; Neoadjuvant therapy; Adverse effect; Internal medicine; Neutropenia; Randomized controlled trial; Febrile neutropenia; Hazard ratio; Surgery; Oncology; Urology; Cancer; Chemotherapy; Confidence interval; Androgen deprivation therapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001445245,0.001132406,0.001456363,0.0004798629,0.0003330663,0.001101514,0.000606288,0.001495294,0.005590794],"category_scores_gemma":[0.00118532,0.000458186,0.001153375,0.0003332912,0.0007278364,0.0006880977,0.000312491,0.00275503,0.001052614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005672511,"about_ca_system_score_gemma":0.001114379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006046468,"about_ca_topic_score_gemma":0.001559455,"domain_scores_codex":[0.9995793,0.0002226039,0.00002737423,0.00004436823,0.00005299103,0.00007333469],"domain_scores_gemma":[0.9992087,0.0002823876,0.0001004279,0.00007223317,0.00003965615,0.0002965559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8625107,0.02186465,0.001631335,0.0007893965,0.0006165411,0.0002632944,0.0001399959,0.0007828127,0.008436389,0.0003597478,0.0038353,0.09876991],"study_design_scores_gemma":[0.6905995,0.2962918,0.004292675,0.00008921079,0.0003991681,0.0003015482,0.00004094953,0.0007600423,0.002508365,0.0002670667,0.004419587,0.00003006281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9697159,0.01185006,0.001654308,0.002541896,0.0007220317,0.00294657,0.002141894,0.0002434173,0.008184002],"genre_scores_gemma":[0.9753931,0.005307893,0.002670205,0.002884827,0.0004833438,0.00244921,0.00261395,0.00004655184,0.008150976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005590794,"threshold_uncertainty_score":0.0187031,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2113337472083064,"score_gpt":0.5171035825473507,"score_spread":0.3057698353390443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}